DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
REVISION OF NIH GUIDELINES SUBCOMMITTEE 
MINUTES OF MEETING^ 
October 15, 1990 
The Revision of the NIH Guidelines Subcommittee (a subcommittee of the Recombinant 
DNA Advisory Committee) was convened at 7:00 p.m. on October 15, 1990, in the 
Marriott Hotel, 5151 Pooks Hill Road, Bethesda, Maryland 20814. Dr. Monica Riley 
(Chair), presided. In accordance with Public Law 92-463, the meeting was open to the 
public. TTie following were present for all or part of the meeting: 
Subcommittee members: 
A1 W. Bourquin 
Don B. Clewell 
Susan Hirano 
Donald Krogstad 
Gerard J. McGarrity 
A subcommittee roster is attached (Attachment). 
National Institutes of Health staff: 
Christine Ireland, OD 
Becky Lawson, OD 
Erwin Peters, OD 
Others: 
Arindam Bose, Pfizer Central Research 
Thomas L. Copmann, Pharmaceutical Manufacturers Association 
Mark Foglesong, Eli Lilly and Company 
Joseph R. Fordham, Nordisk Bioindustrials, Inc. 
Robert Goldberg, Merck Sharp & Dohme Research Laboratory 
Monica Riley 
Moselio Schaechter 
Nelson A. Wivel 
(Executive Secretary) 
^The Revision of the Guidelines Subcommittee is advisory to the 
Recombinant DNA Advisory Committee, and its recommendations should not be 
considered as final or accepted. The Office of Recombinant DNA Activities 
should be consulted for NIH policy on specific issues. 
[316] 
Recombinant DNA Research, Volume 14 
